<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04107870</url>
  </required_header>
  <id_info>
    <org_study_id>PR19054</org_study_id>
    <nct_id>NCT04107870</nct_id>
  </id_info>
  <brief_title>Efficiency of Virtual Reality Exposure Therapy in the Management of Body Dysmorphic Disorders in Female Adolescents With Anorexia Nervosa</brief_title>
  <acronym>ANO-TERV</acronym>
  <official_title>Efficiency of Virtual Reality Exposure Therapy in the Management of Body Dysmorphic Disorder in Female Adolescents With Anorexia Nervosa: a Randomized, Controlled Superiority Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>CHU de Reims</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>CHU de Reims</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Anorexia nervosa is defined in DSM V as a quantitative and qualitative dietary restriction&#xD;
      resulting in significant weight loss, intense fear of weight gain, altered weight and body&#xD;
      shape perception (body dysmorphic disorder) and low self-esteem influenced by weight or body&#xD;
      shape. Body dysmorphic disorder is the most difficult symptom to manage in anorexia nervosa&#xD;
      and its persistence is a factor associated with relapse.&#xD;
&#xD;
      Virtual reality exposure therapy has proven its effectiveness in the management of&#xD;
      post-traumatic stress disorder in the military and is a widely used therapy. The&#xD;
      effectiveness of this treatment using new technologies has not yet been studied for the&#xD;
      treatment of body dysmorphic disorder in anorexia nervosa and is not used routinely. It could&#xD;
      represent an interesting alternative to the physical approach in psychomotor therapy,&#xD;
      traditionally offered to patients suffering from anorexia nervosa. It is important to&#xD;
      evaluate the effectiveness of virtual reality exposure therapy in the management of body&#xD;
      dysmorphic disorder in patients with anorexia nervosa by comparing these two care techniques.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The aim of this study is to evaluate the effectiveness of Virtual Reality Exposure Therapy in&#xD;
      the management of body dysmorphic disorder in patients with anorexia nervosa, compared to the&#xD;
      traditionally proposed body approach in psychomotor therapy.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 20, 2021</start_date>
  <completion_date type="Anticipated">September 20, 2026</completion_date>
  <primary_completion_date type="Anticipated">March 20, 2025</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Body Shape Questionnaire</measure>
    <time_frame>12 months</time_frame>
    <description>The Body Shape Questionnaire (BSQ) measures concerns about body shape. The BSQ can be divided into 4 sub scores: &quot;avoidance and social shame of body exposure&quot;, &quot;body dissatisfaction with lower body parts&quot;, &quot;use of laxatives and vomiting to reduce body dissatisfaction&quot; and &quot;inappropriate cognitions and behaviours to control weight&quot;.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Eating Disorder Inventory</measure>
    <time_frame>12 months</time_frame>
    <description>Eating Disorder Inventory (EDI-2) is a self questionnaire to assess the severity of symptoms of eating disorders and to evaluate their changes</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Anorexia Nervosa</condition>
  <arm_group>
    <arm_group_label>Virtual Reality Exposure Therapy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Female adolescents aged 13 to 18 are proposed virtual reality exposure therapy sessions, accompanied by a cognitive and behavioral therapy (CBT) therapist, to work on their body representations</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Psychomotor Therapy</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Psychomotor therapy sessions are proposed to female adolescents aged 13 to 18 years, ac-companied by a psychomotor therapist, to work on their body representations.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Virtual Reality Exposure Therapy sessions</intervention_name>
    <description>Female adolescents aged 13 to 18 are proposed virtual reality exposure therapy sessions, accompanied by a cognitive and behavioral therapy (CBT) therapist, to work on their body representations</description>
    <arm_group_label>Virtual Reality Exposure Therapy</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Psychomotor therapy sessions</intervention_name>
    <description>Psychomotor therapy sessions are proposed to female adolescents aged 13 to 18 years, ac-companied by a psychomotor therapist, to work on their body representations.</description>
    <arm_group_label>Psychomotor Therapy</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion criteria :&#xD;
&#xD;
          -  Female adolescents aged 13 to 18&#xD;
&#xD;
          -  with a diagnosis of anorexia nervosa of all types (including purgative and&#xD;
             hyperphagic) according to the DSM-V&#xD;
&#xD;
          -  French as first language&#xD;
&#xD;
          -  agreed to participate in the study&#xD;
&#xD;
          -  parental authority holders accepting her participation in the study&#xD;
&#xD;
          -  affiliated to a social security system&#xD;
&#xD;
        Patients will not be included in the study:&#xD;
&#xD;
          -  with a somatic severity criterion:&#xD;
&#xD;
               -  Total aphagia&#xD;
&#xD;
               -  Body mass index (BMI) &lt; 14kg/m² for those over 17 years of age, BMI &lt; 13.2kg/m²&#xD;
                  for those aged 15-16 and BMI &lt; 12.7kg/m² for those aged 13-14.&#xD;
&#xD;
               -  Confusion&#xD;
&#xD;
               -  Bradycardia &lt;40/min, Tachycardia&#xD;
&#xD;
               -  Blood pressure &lt; 80/50mmHg&#xD;
&#xD;
               -  Hypothermia &lt;35.5°C&#xD;
&#xD;
               -  Severe metabolic disorders: hypokalemia &lt; 2.5 mmol/l, hyponatremia &lt; 125mmol/l or&#xD;
                  hypernatremia &gt; 150 mmol/l, hypophosphoremia &lt; 0.5 mmol/l&#xD;
&#xD;
               -  Acetonuria, hypoglycemia &lt; 0.6g/l&#xD;
&#xD;
               -  Creatinine elevation &gt; 100micromol/l&#xD;
&#xD;
               -  Cytolysis &gt; 4N&#xD;
&#xD;
               -  Leuconeutropenia &lt;1000/mm3&#xD;
&#xD;
               -  Thrombocytopenia &lt;6000000/mm3&#xD;
&#xD;
               -  Suicide attempt in the last month before inclusion&#xD;
&#xD;
               -  Receiving benzodiazepine treatment outside the prescription limits.&#xD;
&#xD;
          -  Psychotic patients or patients with psychoactive substance addiction according to MINI&#xD;
             KID criteria (Sheehan DV et al. Reliability and validity of the Mini International&#xD;
             Neuropsychiatric Interview for children and adolescents (MINI Kid). J Clin Psychiatry&#xD;
             2010;71(3):313-326).&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>13 Years</minimum_age>
    <maximum_age>17 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Julien EUTROPE</last_name>
    <phone>03 26 78 39 56</phone>
    <phone_ext>0033</phone_ext>
    <email>jeutrope@chu-reims.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Damien JOLLY</name>
      <address>
        <city>Reims</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Julien EUTROPE</last_name>
      <phone>03 26 78 39 56</phone>
      <phone_ext>0033</phone_ext>
      <email>jeutrope@chu-reims.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>June 2021</verification_date>
  <study_first_submitted>September 26, 2019</study_first_submitted>
  <study_first_submitted_qc>September 26, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">September 27, 2019</study_first_posted>
  <last_update_submitted>June 25, 2021</last_update_submitted>
  <last_update_submitted_qc>June 25, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">June 28, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>ANOREXIA NERVOSA</keyword>
  <keyword>FEMALE ADOLESCENTS</keyword>
  <keyword>BODY DYSMORPHIC DISORDER</keyword>
  <keyword>VIRTUAL REALITY EXPOSURE THERAPY</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anorexia</mesh_term>
    <mesh_term>Anorexia Nervosa</mesh_term>
    <mesh_term>Body Dysmorphic Disorders</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

